Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - TOTAL ASSETS
Total Assets AKBA - Akebia Therapeutics, Inc.
242 M
LAST VALUE
-32.18%
2 YEAR CAGR
-24.67%
5 YEAR CAGR
21.43%
10 YEAR CAGR